These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31255634)

  • 1. Epidemiology of adult meningitis during antiretroviral therapy scale-up in southern Africa: Results from the Botswana national meningitis survey.
    Tenforde MW; Mokomane M; Leeme T; Tlhako N; Tsholo K; Ramodimoosi C; Dube B; Mokobela KO; Tawanana E; Chebani T; Pilatwe T; Hurt WJ; Mitchell HK; Molefi M; Mullan PC; Guthrie BL; Farquhar C; Steenhoff AP; Mine M; Jarvis JN
    J Infect; 2019 Sep; 79(3):212-219. PubMed ID: 31255634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.
    Tenforde MW; Mokomane M; Leeme T; Patel RKK; Lekwape N; Ramodimoosi C; Dube B; Williams EA; Mokobela KO; Tawanana E; Pilatwe T; Hurt WJ; Mitchell H; Banda DL; Stone H; Molefi M; Mokgacha K; Phillips H; Mullan PC; Steenhoff AP; Mashalla Y; Mine M; Jarvis JN
    Clin Infect Dis; 2017 Sep; 65(5):779-786. PubMed ID: 28505328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana.
    Milburn J; Ntwayagae O; Suresh R; Ngoni K; Northcott C; Penney J; Kinsella M; Mechie I; Ensor S; Thamae G; Leeme T; Lawrence DS; Chebani T; Grint D; Tenforde MW; Avalos A; Ramaabya D; Ogando J; Mokomane M; Mine M; Jarvis JN
    Clin Infect Dis; 2024 Aug; 79(2):462-468. PubMed ID: 38330295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of Pediatric Meningitis in Botswana: Results From a 16-Year National Meningitis Audit.
    Mitchell HK; Mokomane M; Leeme T; Tlhako N; Tsholo K; Ramodimoosi C; Dube B; Mokobela KO; Tawanana E; Chebani T; Setlhake P; Pilatwe T; Hurt WJ; Molefi M; Mullan PC; Steenhoff AP; Mine M; Jarvis JN; Tenforde MW
    Pediatr Infect Dis J; 2019 Sep; 38(9):906-911. PubMed ID: 31261367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of cryptococcal meningitis in HIV-1 infected patients in north central Nigeria.
    Gomerep SS; Idoko JA; Ladep NG; Ugoya SO; Obaseki D; Agbaji OA; Agaba P; Akanbi MO; Badung BP; Otitoloju O
    Niger J Med; 2010; 19(4):395-9. PubMed ID: 21526627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in adult patients with culture-positive and culture-negative meningitis in the Botswana national meningitis survey: a prevalent cohort study.
    Tenforde MW; Mokomane M; Leeme TB; Tlhako N; Tsholo K; Chebani T; Stephenson A; Hutton J; Mitchell HK; Patel RK; Hurt WJ; Pilatwe T; Masupe T; Molefi M; Guthrie BL; Farquhar C; Mine M; Jarvis JN
    Lancet Infect Dis; 2019 Jul; 19(7):740-749. PubMed ID: 31250824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.
    Hiesgen J; Schutte C; Olorunju S; Retief J
    Int J STD AIDS; 2017 Apr; 28(5):480-485. PubMed ID: 27255493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
    Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
    Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy.
    Bamba S; Lortholary O; Sawadogo A; Millogo A; Guiguemdé RT; Bretagne S
    AIDS; 2012 May; 26(8):1039-41. PubMed ID: 22552479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of cryptococcal meningitis in Malawi.
    Makombe SD; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    Trop Doct; 2009 Jan; 39(1):32-4. PubMed ID: 19211421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana.
    Opintan JA; Awadzi BK; Biney IJK; Ganu V; Doe R; Kenu E; Adu RF; Osei MM; Akumwena A; Grigg ME; Fahle GA; Newman MJ; Williamson PR; Lartey M
    Trans R Soc Trop Med Hyg; 2017 Oct; 111(10):464-471. PubMed ID: 29373741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana.
    Steele KT; Thakur R; Nthobatsang R; Steenhoff AP; Bisson GP
    Med Mycol; 2010 Dec; 48(8):1112-5. PubMed ID: 20438294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
    Rhein J; Morawski BM; Hullsiek KH; Nabeta HW; Kiggundu R; Tugume L; Musubire A; Akampurira A; Smith KD; Alhadab A; Williams DA; Abassi M; Bahr NC; Velamakanni SS; Fisher J; Nielsen K; Meya DB; Boulware DR;
    Lancet Infect Dis; 2016 Jul; 16(7):809-818. PubMed ID: 26971081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
    Oyella J; Meya D; Bajunirwe F; Kamya MR
    J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
    Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
    J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study.
    Mbangiwa T; Sturny-Leclère A; Lechiile K; Kajanga C; Boyer-Chammard T; Hoving JC; Leeme T; Moyo M; Youssouf N; Lawrence DS; Mwandumba H; Mosepele M; Harrison TS; Jarvis JN; Lortholary O; Alanio A;
    Lancet Microbe; 2024 Mar; 5(3):e261-e271. PubMed ID: 38342110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
    Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
    Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.